James Mccloskey
Hematology & Oncology · Hackensack, NJ
CMS Profile ID: 648059 · NPI: 1992951149
Total Disclosed General Payments
$607,387.08
General-payment records
407
CMS Program Year
2025
Most of this (about 80%) was payments for services other than consulting, including faculty or speaking services outside continuing education.
Payments by Type
| Payment Type | Amount |
|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $488,642.34 |
| Travel and Lodging | $66,383.37 |
| Consulting Fee | $27,174.28 |
| Honoraria | $18,003.00 |
| Food and Beverage | $7,184.09 |
Top Paying Companies
| Manufacturer / GPO | Amount |
|---|---|
| GlaxoSmithKline, LLC. | $108,112.47 |
| Syndax Pharmaceuticals, Inc. | $100,148.56 |
| SOBI, INC | $68,815.27 |
| Geron Corporation | $68,448.77 |
| Takeda Pharmaceuticals U.S.A., Inc. | $59,965.49 |
| PharmaEssentia USA Corporation | $59,793.17 |
Top contributing companies shown; smaller payers may be omitted.
These totals are computed from the official CMS Open Payments program-year 2025 general-payment
file. To see the full, authoritative record for this provider — including research payments and
line-item detail — look them up by exact NPI 1992951149 on the
official CMS Open Payments portal.
Verify this record with CMS
- Confirm the provider's exact NPI: 1992951149.
- Select program year 2025 and general payments in the CMS portal.
- Check individual payment records and their nature-of-payment categories.